eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2010
vol. 14
 
Share:
Share:
abstract:
Original paper

Efficacy and safety of surgical and chemoimmunotherapy combination treatment in patients with renal carcinoma and pulmonary metastases

Tomasz Syryło
,
Jakub Żołnierek
,
Cezary Szczylik
,
Henryk Zieliński
,
Leszek Bortnowski
,
Andrzej Bogdanowicz

Współczesna Onkologia (2010) vol. 14; 1 (39–43)
Online publish date: 2010/02/25
View full text Get citation
 
PlumX metrics:

Background: Renal cell carcinoma (RCC) amounts to 3% of solid tumours in adults. In about 30% of newly diagnosed RCC patients metastases are found, the majority of them in the lungs.
The aim of the study is to assess remission of lung metastases of advanced renal cancer after nephrectomy and chemoimmunotherapy. Prior to systemic treatment all patients were subject to nephrectomy (without metastasectomy), and metastatic spread of the disease was documented by CT scan. The therapy was based on IL-2 s.c., IFN- s.c., and 5-FU i.v. Performance status was assessed according to the ECOG scale, and response of target lesions according to RECIST criteria.
Results: ECOG score in 54 patients: 0 in 5 patients, 1 in 43, and 2 in 6. After chemoimmunotherapy, 5 complete responses (9%) and 12 partial responses (22%) were observed. An objective response was noted in 17 cases. Mean CR duration was 24 months (which significantly prolonged patients’ survival). ECOG PS: 0 – 0, 1 – 4 patients, 2 – 1 pa-tient. Mean PR duration was 12 months (usually progression of cancer). The regimen used showed only transient toxicity with good treatment tolerance by patients.
Conclusions: 1. Combined nephrectomy and chemoimmunotherapy is an effective and safe treatment option in patients with renal cancer and pulmonary metastases.
2. As a result of the administered chemoimmunotherapy 5 CRs were achieved, which significantly prolonged patients’ survival.
3. Treatment of RCC patients should be carried out in specialised centres and should be interdisciplinary in nature.
keywords:

metastatic renal cell carcinoma, pulmonary metastases, nephrectomy, chemoimmunotherapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.